Wednesday May 3rd, 2006
The Jane Mallet Theatre
St. Lawrence Centre
27 Front Street East
Toronto, Ontario
10:00 a.m. EDT
CALGARY, May 2 /CNW/ - The Westaim Corporation will hold its Annual
General Meeting of Shareholders and Investor Briefing on Wednesday, May 3,
2006 at 10:00 a.m. EDT. The meeting will be held at the Jane Mallet Theatre,
St. Lawrence Centre, 27 Front Street East, in downtown Toronto.
Both the meeting and investor briefing will be webcast live at
www.westaim.com. An audio file of the webcast will be archived and posted on
the Westaim website.
The Westaim Corporation's technology investments include: NUCRYST
Pharmaceuticals (NASDAQ: NCST; TSX: NCS), which researches, develops and
commercializes medical devices and pharmaceutical products that fight
infection and inflammation based on its nanocrystalline silver technology; and
iFire Technology, which has developed a revolutionary low-cost flat panel
display. Westaim's common shares are listed on NASDAQ under the symbol WEDX
and on The Toronto Stock Exchange under the trading symbol WED.
%SEDAR: 00002793E
The Westaim Corporation Annual General Meeting of Shareholders
Earlier from Aventus Capital
- Webcast Advisory - The Westaim Corporation Webcast of Annual Meeting of Shareholders and Investor Briefing
- Webcast Advisory - The Westaim Corporation investor briefing and iFire Technology Corp. update
- Westaim announces 2005 year-end results
- Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2005 Fourth Quarter and Year-End Results
- Westaim Corporation - 2005 Fourth Quarter and Year End Results Webcast - February 15, 2006
Later from Aventus Capital
- Westaim announces 2006 first quarter results
- Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2006 Second Quarter Results
- Westaim Corporation - 2006 Second Quarter Results Webcast - August 9, 2006
- Westaim announces 2006 second quarter results
- iFire's TDEL technology recognized as a key flat panel display technology by Chinese government
Follow Aventus Capital into a list and get an email when it puts out news.
Follow Aventus Capital